Tagged with EG

Pharma Legal Handbook Want to know more about patents and trademarks in Bolivian pharma? Read on! Prepared in association with Indacochea & Asociados, a leading Bolivian law firm, this is an extract from The Pharma Legal Handbook: Bolivia, available to purchase here for USD 99.   1. What are the basic requirements to obtain patent and trademark…

Pharma Legal Handbook An insight into regulatory reforms in Bolivian Pharma. Prepared in association with Indacochea & Asociados, a leading Bolivian law firm, this is an extract from The Pharma Legal Handbook: Bolivia, available to purchase here for USD 99.   1. Are there proposals for reform or significant change to the healthcare system?…

Turkey Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He also shares his advice on navigating the Turkish market and his visions for the future.   Running a pharmaceutical company…

USA Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses the Creating and Restoring Equal Access to Equivalent Samples Act (CREATES) and how it will improve access to medicines and restore healthy competition to the market.    American taxpayers, along with millions of patients, will benefit…

Spain After a recent course of political shifts, Spain now finds itself with a new minister of health; the third since this past June.  Maria Luisa Carcedo, who was named as the Spanish minister of health by Prime Minister Pedro Sanchez on September 11, has replaced Carmen Monton, who resigned after…

Portugal Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of the health sector. Here she examines Portugal’s new regulatory framework on cannabis for medicinal purposes.    What will actually change considering that in Portugal (and in the European Union) it is already possible to obtain a marketing…

Malaysia Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory ecosystem in Malaysia and the important role that the Malaysian regulator has in the ASEAN region. He also takes time to explain the upcoming priorities to further establish…

Mexico Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health in Mexico through innovative medicine. Here Cristobal discusses Mexico’s regulatory landscape and the countries advances in healthcare.    Mexico has…

Malaysia Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.   Oncology is the future, and we want to introduce the products in Servier’s pipeline to Malaysia as and when…

Malaysia Datuk Seri Dr. Haji Dzulkefly bin Ahmad, Malaysia’s Minister of Health, sets out his vision and key priorities for healthcare in the country over the course of the new parliamentary session.   My approach is to emphasise primary healthcare by allocating enough resources to empower the public health delivery system…

Canada John Fowler founded 7ACRES, a licensed producer of cannabis, in 2013. In 2014, 7ACRES went over to become part of The Supreme Cannabis Company, which today stands as a unique business model in the Canadian medical cannabis sector.   Indeed, The Supreme Cannabis Company operates as a wholesaler, a decision…

Pharma Legal Handbook The legal framework for regulatory reforms in Turkey. Prepared in association with Moroğlu Arseven, a leading Turkish law firm, this is an extract from The Pharma Legal Handbook: Turkey, available to purchase here for GBP 75.   1. Are there proposals for reform or significant change to the healthcare system? No…